- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01114269
Kohortenstudie im Voraus bestimmen
VORAB BESTIMMEN: Biologische Marker und MRT-SCD-Kohortenstudie
This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.
Studienübersicht
Status
Detaillierte Beschreibung
The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
Alberta
-
Edmonton, Alberta, Kanada, T6G 2B7
- University of Alberta
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V5Z 1M9
- Vancouver General Hospital
-
-
Ontario
-
Mississauga, Ontario, Kanada, L5B 2P7
- Mississauga Clinical Research Centre
-
-
-
-
-
Rio Piedras, Puerto Rico, 00924
- Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe
-
-
-
-
Alaska
-
Anchorage, Alaska, Vereinigte Staaten, 99508
- Alaska Heart Institute
-
-
Arizona
-
Glendale, Arizona, Vereinigte Staaten, 85306
- Phoenix Heart, PLLC
-
Phoenix, Arizona, Vereinigte Staaten, 85032
- Cardiovascular Consultants
-
-
California
-
Banning, California, Vereinigte Staaten, 92220
- Beaver Medical Group/Clinical Care Research
-
-
Colorado
-
Colorado Springs, Colorado, Vereinigte Staaten, 80909
- Memorial Health System
-
Denver, Colorado, Vereinigte Staaten, 80204
- Colorado Heart and Vascular
-
-
Florida
-
Brandon, Florida, Vereinigte Staaten, 33511
- Bay Area Cardiology Associates, P.A.
-
Gainesville, Florida, Vereinigte Staaten, 32610
- University of Florida - Gainsville
-
Miami, Florida, Vereinigte Staaten, 33135
- Reliable Clinical Research
-
Miami Beach, Florida, Vereinigte Staaten, 33140
- Mount Sinai Medical Center
-
Orlando, Florida, Vereinigte Staaten, 32804
- Florida Hospital
-
Orlando, Florida, Vereinigte Staaten, 32806
- Orlando Regional Medical Center
-
Palm Beach Gardens, Florida, Vereinigte Staaten, 33410
- Palm Beach Gardens Research Center
-
Sarasota, Florida, Vereinigte Staaten, 34233
- Velella Research
-
Tallahassee, Florida, Vereinigte Staaten, 32308
- Tallahassee Research Institute, Inc.
-
West Palm Beach, Florida, Vereinigte Staaten, 33401
- Cardiology Associates of Palm Beach - West Palm Beach
-
-
Georgia
-
Covington, Georgia, Vereinigte Staaten, 30014
- Georgia Heart Specialist
-
Gainesville, Georgia, Vereinigte Staaten, 30501
- Northeast Georgia Heart Center, P.C.
-
-
Illinois
-
Chicago, Illinois, Vereinigte Staaten, 60637
- University of Chicago
-
Chicago, Illinois, Vereinigte Staaten, 60643
- Advocate Medical Group
-
Chicago, Illinois, Vereinigte Staaten, 60657
- Advocate Medical Group - Heart and Vascular of IL
-
Melrose Park, Illinois, Vereinigte Staaten, 60160
- Consultants in Cardiovascular Medicine
-
-
Indiana
-
Anderson, Indiana, Vereinigte Staaten, 46011
- Community Heart and Vascular
-
-
Iowa
-
West Des Moines, Iowa, Vereinigte Staaten, 50266
- Iowa Heart Center
-
-
Kansas
-
Kansas City, Kansas, Vereinigte Staaten, 66160
- The University of Kansas
-
-
Kentucky
-
Lexington, Kentucky, Vereinigte Staaten, 40503
- Baptist Health Lexington
-
-
Louisiana
-
Houma, Louisiana, Vereinigte Staaten, 70363
- Leonard J. Chabert Medical Center
-
-
Maine
-
Auburn, Maine, Vereinigte Staaten, 04210
- Maine Research Associates
-
Lewiston, Maine, Vereinigte Staaten, 04240
- Maine Research Associates - Lewiston
-
-
Maryland
-
Baltimore, Maryland, Vereinigte Staaten, 21201
- University of Maryland Medical Center
-
-
Massachusetts
-
Ayer, Massachusetts, Vereinigte Staaten, 01432
- Primary Care Cardiology Research
-
Boston, Massachusetts, Vereinigte Staaten, 02115
- Brigham and Women's Hospital
-
Fall River, Massachusetts, Vereinigte Staaten, 02720
- NECCR Internal Medicine and Cardiology Associates, LLC
-
North Dartmouth, Massachusetts, Vereinigte Staaten, 02747
- Hawthorn Medical Associates
-
Springfield, Massachusetts, Vereinigte Staaten, 01199
- Baystate Cardiology
-
-
Michigan
-
Ann Arbor, Michigan, Vereinigte Staaten, 48109
- University of Michigan Medical Center
-
Dearborn, Michigan, Vereinigte Staaten, 48124
- Oakwood Hospital & Medical Center
-
Mount Clemens, Michigan, Vereinigte Staaten, 48043
- McLaren Medical Center - Macomb
-
Ypsilanti, Michigan, Vereinigte Staaten, 48197
- Michigan Heart
-
-
Minnesota
-
Minneapolis, Minnesota, Vereinigte Staaten, 55417
- Minneapolis VA Medical Center
-
-
Missouri
-
Columbia, Missouri, Vereinigte Staaten, 65201
- University of Missouri Health Care
-
-
Montana
-
Kalispell, Montana, Vereinigte Staaten, 59901
- Glacier View Cardiology
-
-
Nebraska
-
Omaha, Nebraska, Vereinigte Staaten, 68131
- The Cardiac Center of Creighton University
-
-
New Jersey
-
Bridgewater, New Jersey, Vereinigte Staaten, 08807
- Advanced Heartcare, LLC
-
Paterson, New Jersey, Vereinigte Staaten, 07503
- St. Joseph Regional Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, Vereinigte Staaten, 87108
- New Mexico VA Healthcare Systems
-
-
New York
-
Albany, New York, Vereinigte Staaten, 12205
- Albany Associates Cardiology
-
Brooklyn, New York, Vereinigte Staaten, 11219
- Maimonides Medical Center
-
Buffalo, New York, Vereinigte Staaten, 14203
- Buffalo General Hospital/Kaleida Health
-
Jamaica, New York, Vereinigte Staaten, 11418
- Jamaica Hospital Medical Center
-
Kingston, New York, Vereinigte Staaten, 12401
- Mid-Valley Cardiology
-
Mineola, New York, Vereinigte Staaten, 11501
- Winthrop-University Hospital
-
New York, New York, Vereinigte Staaten, 10001
- Gotham Cardiovascular
-
New York, New York, Vereinigte Staaten, 10032
- Columbia University Health Center
-
Stony Brook, New York, Vereinigte Staaten, 11794
- Stony Brook University Medical Center
-
Utica, New York, Vereinigte Staaten, 13501
- St. Elizabeth Medical Center - Hotvedt
-
-
North Carolina
-
Asheville, North Carolina, Vereinigte Staaten, 28801
- Asheville Cardiology Associates
-
Elizabeth City, North Carolina, Vereinigte Staaten, 27909
- Eastern Carolina Cardiovascular
-
Lenoir, North Carolina, Vereinigte Staaten, 28645
- Northstate Clinical Research
-
Pinehurst, North Carolina, Vereinigte Staaten, 28374
- Pinehurst Medical Clinic, Inc.
-
Sanford, North Carolina, Vereinigte Staaten, 27330
- Sanford Cardiology
-
Winston-Salem, North Carolina, Vereinigte Staaten, 27157
- Wake Forest
-
-
Ohio
-
Akron, Ohio, Vereinigte Staaten, 44304
- Northeast Ohio Cardiovascular Specialists
-
Cincinnati, Ohio, Vereinigte Staaten, 45267
- University of Cincinnati
-
Cleveland, Ohio, Vereinigte Staaten, 44109
- MetroHealth Medical Center
-
Elyria, Ohio, Vereinigte Staaten, 44035
- North Ohio Research, Ltd.
-
Fairfield, Ohio, Vereinigte Staaten, 45014
- Mercy Medical Associates
-
Toledo, Ohio, Vereinigte Staaten, 43615
- Northwest Ohio Cardiology Consultants/The Toledo Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73120
- Oklahoma Foundation for Cardiovascular Research
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73104
- Oklahoma City VA Medical Center Veterans Research and Education Foundation
-
-
Pennsylvania
-
Abington, Pennsylvania, Vereinigte Staaten, 19001
- Abington Memorial Hospital
-
Bethlehem, Pennsylvania, Vereinigte Staaten, 18018
- St. Luke's Bethlehem
-
Doylestown, Pennsylvania, Vereinigte Staaten, 18901
- Doylestown Cardiology Associates
-
Pittsburgh, Pennsylvania, Vereinigte Staaten, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Vereinigte Staaten, 15213
- University of Pittsburgh Medical Center
-
-
South Carolina
-
Anderson, South Carolina, Vereinigte Staaten, 29621
- AnMed Health
-
Charleston, South Carolina, Vereinigte Staaten, 29425
- VA Medical Center - Charleston
-
Rock Hill, South Carolina, Vereinigte Staaten, 29732
- Carolina Cardiology Associates
-
-
South Dakota
-
Rapid City, South Dakota, Vereinigte Staaten, 57701
- Black Hills Cardiovascular Research
-
-
Tennessee
-
Knoxville, Tennessee, Vereinigte Staaten, 37917
- Cardiovasular Research of Knoxville
-
Memphis, Tennessee, Vereinigte Staaten, 38104
- Memphis VA Medical Center
-
-
Texas
-
Houston, Texas, Vereinigte Staaten, 77030
- St. Luke's Episcopal Hospital
-
Houston, Texas, Vereinigte Staaten, 77074
- Non-Invasive Cardiovascular PA
-
Waco, Texas, Vereinigte Staaten, 76712
- Providence Health Center
-
-
Utah
-
Murray, Utah, Vereinigte Staaten, 84157
- Intermountain Medical Center
-
-
Virginia
-
Virginia Beach, Virginia, Vereinigte Staaten, 23454
- Cardiovascular Associates Virginia Beach
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Participants have been recruited throughout multicenter sites participating in the PRE-DETERMINE Cohort Study. Patients with a history of coronary artery disease and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%) have been enrolled. The clinical study staff at each site, which was either a research nurse, fellow, or physician approached eligible patients to discuss their potential participation.
Beschreibung
Inclusion Criteria:
-
Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.
-
LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.
-
If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.
-
Patients aged 18 years or above
-
CAD will be defined as evidence of one of the following two (2) criteria:
- Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography
- Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)
-
MI can be documented in the following ways:
-
From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:
- Symptoms of Ischemia
- ECG changes indicative of new ischemia (new ST-T changes or new LBBB)
- Development of pathological Q waves
- Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
-
If no report from the MI hospitalization is available, prior MI can be met by either of the following:
- Development of pathological Q waves
- Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause
-
-
Exclusion Criteria:
- History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).
- Unexplained syncope
- Current or planned implantable cardiac defibrillator (ICD)
- Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)
- Metastatic cancer
- Marked valvular heart disease requiring surgical intervention
- Current or planned cardiac, renal or liver transplant
- Current alcohol or drug abuse
- Unwilling or unable to provide informed consent
- LVEF <35% with Class II-IV CHF or LVEF <30%
- Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: COHORT
- Zeitperspektiven: PROSPECTIVE
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation.
Zeitfenster: Median follow-up estimated to be 10.7 years
|
A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation. |
Median follow-up estimated to be 10.7 years
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
ICD-Implantation
Zeitfenster: Die mittlere Nachbeobachtungszeit wird auf 10,7 Jahre geschätzt
|
Die mittlere Nachbeobachtungszeit wird auf 10,7 Jahre geschätzt
|
|
|
Gesamte kardiale Sterblichkeit
Zeitfenster: Die mittlere Nachbeobachtungszeit wird auf 10,7 Jahre geschätzt
|
Die mittlere Nachbeobachtungszeit wird auf 10,7 Jahre geschätzt
|
|
|
Gesamtsterblichkeit
Zeitfenster: Die mittlere Nachbeobachtungszeit wird auf 10,7 Jahre geschätzt
|
Die mittlere Nachbeobachtungszeit wird auf 10,7 Jahre geschätzt
|
|
|
ICD Shock
Zeitfenster: Median follow-up estimated to be 10.7 years
|
ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint. |
Median follow-up estimated to be 10.7 years
|
|
Non-Sudden or Arrhythmic Causes of Mortality
Zeitfenster: Median follow-up estimated to be 10.7 years
|
Competing causes of mortality in competing risk analyses. |
Median follow-up estimated to be 10.7 years
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Christine M Albert, M.D., M.P.H., Brigham and Women's Hospital
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Silverman MG, Yeri A, Moorthy MV, Camacho Garcia F, Chatterjee NA, Glinge CSA, Tfelt-Hansen J, Salvador AM, Pico AR, Shah R, Albert CM, Das S. Circulating miRNAs and Risk of Sudden Death in Patients With Coronary Heart Disease. JACC Clin Electrophysiol. 2020 Jan;6(1):70-79. doi: 10.1016/j.jacep.2019.08.011. Epub 2019 Oct 30.
- Lee DC, Albert CM, Narula D, Kadish AH, Panicker GK, Wu E, Schaechter A, Pester J, Chatterjee NA, Cook NR, Goldberger JJ. Estimating Myocardial Infarction Size With a Simple Electrocardiographic Marker Score. J Am Heart Assoc. 2020 Feb 4;9(3):e014205. doi: 10.1161/JAHA.119.014205. Epub 2020 Jan 24.
- Chatterjee NA, Tikkanen JT, Panicker GK, Narula D, Lee DC, Kentta T, Junttila JM, Cook NR, Kadish A, Goldberger JJ, Huikuri HV, Albert CM; PREDETERMINE Investigators. Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease. Eur Heart J. 2020 Jun 1;41(21):1988-1999. doi: 10.1093/eurheartj/ehaa177.
- Panicker GK, Narula DD, Albert CM, Lee DC, Kothari S, Goldberger JJ, Cook N, Schaechter A, Kim E, Moorthy MV, Pester J, Chatterjee NA, Kadish AH, Karnad DR. Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarction. Ann Noninvasive Electrocardiol. 2021 Mar;26(2):e12812. doi: 10.1111/anec.12812. Epub 2020 Oct 30.
- Venkateswaran RV, Moorthy MV, Chatterjee NA, Pester J, Kadish AH, Lee DC, Cook NR, Albert CM. Diabetes and Risk of Sudden Death in Coronary Artery Disease Patients Without Severe Systolic Dysfunction. JACC Clin Electrophysiol. 2021 Dec;7(12):1604-1614. doi: 10.1016/j.jacep.2021.05.014. Epub 2021 Jul 28.
- Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol. 2017 Jul 1;2(7):767-774. doi: 10.1001/jamacardio.2017.1413.
- Sandhu RK, Dron JS, Liu Y, Moorthy MV, Chatterjee NA, Ellinor PT, Chasman DI, Cook NR, Khera AV, Albert CM. Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function. J Am Coll Cardiol. 2022 Aug 30;80(9):873-883. doi: 10.1016/j.jacc.2022.05.049.
- Peek N, Hindricks G, Akbarov A, Tijssen JGP, Jenkins DA, Kapacee Z, Parkes LM, van der Geest RJ, Longato E, Sprague D, Taleb Y, Ong M, Miller CA, Shamloo AS, Albert C, Barthel P, Boveda S, Braunschweig F, Johansen JB, Cook N, de Chillou C, Elders P, Faxen J, Friede T, Fusini L, Gale CP, Jarkovsky J, Jouven X, Junttila J, Kautzner J, Kiviniemi A, Kutyifa V, Leclercq C, Lee DC, Leigh J, Lenarczyk R, Leyva F, Maeng M, Manca A, Marijon E, Marschall U, Merino JL, Mont L, Nielsen JC, Olsen T, Pester J, Pontone G, Roca I, Schmidt G, Schwartz PJ, Sticherling C, Suleiman M, Taborsky M, Tan HL, Tfelt-Hansen J, Thiele H, Tomaselli GF, Verstraelen T, Vinayagamoorthy M, Olesen KKW, Wilde A, Willems R, Wu KC, Zabel M, Martin GP, Dagres N. Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts. Eur Heart J. 2024 Nov 14;45(43):4616-4626. doi: 10.1093/eurheartj/ehae326.
- Chatterjee NA, Moorthy MV, Pester J, Schaecter A, Panicker GK, Narula D, Lee DC, Goldberger JJ, Kadish A, Cook NR, Albert CM; PRE-DETERMINE Study Group. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction. JAMA Cardiol. 2018 Jul 1;3(7):591-600. doi: 10.1001/jamacardio.2018.1049.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Geschätzt)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Gefäßerkrankungen
- Herz-Kreislauf-Erkrankungen
- Pathologische Prozesse
- Herzkrankheiten
- Tod
- Infarkt
- Nekrose
- Ventrikuläre Dysfunktion
- Arteriosklerose
- Arterielle Verschlusskrankheiten
- Koronare Krankheit
- Myokardischämie
- Ischämie
- Herzstillstand
- Tod, plötzlich
- Pathologische Zustände, Anzeichen und Symptome
- Ventrikuläre Dysfunktion, links
- Koronare Herzkrankheit
- Tod, Plötzlich, Herz
- Herzinfarkt
Andere Studien-ID-Nummern
- 2007P000840
- R01HL091069 (US NIH Stipendium/Vertrag)
- R01HL165840 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .